Obstetrics

Electrosurgery Market to be Worth $8.99 Billion by 2031 - Exclusive Report by Meticulous Research®

Retrieved on: 
星期三, 五月 8, 2024
Smoke, United Nations, Risk, General surgery, Surgeon, Electrosurgery, Medtronic, Smith, Olympus Corporation, Boston Scientific, Lip, Perforation, Prevalence, Skin, Medical tourism, Spine, Obstetrics, Ageing, Argon, Plasma, Conditional sentence, Hospital, Generator, Geography, ENT, Johnson & Johnson, Bleeding, Incidence, Government, BPH, Stryker Corporation, Steris, ASC, Disease, United, Patient, Coagulation, Circulatory system, Cancer, Growth, Dentistry

Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.

Key Points: 
  • Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.
  • However, the risks associated with electrosurgical procedures and the shortage of surgeons restrain the growth of this market.
  • The report also includes an extensive assessment of the key growth strategies adopted by leading market players over the past three years.
  • The global electrosurgery market has witnessed several product launches, product approvals, acquisitions, and expansions in the last couple of years.

Electrosurgery Market to be Worth $8.99 Billion by 2031 - Exclusive Report by Meticulous Research®

Retrieved on: 
星期三, 五月 8, 2024
Smoke, United Nations, Risk, General surgery, Surgeon, Electrosurgery, Medtronic, Smith, Olympus Corporation, Boston Scientific, Lip, Perforation, Prevalence, Skin, Medical tourism, Spine, Obstetrics, Ageing, Argon, Plasma, Conditional sentence, Hospital, Generator, Geography, ENT, Johnson & Johnson, Bleeding, Incidence, Government, BPH, Stryker Corporation, Steris, ASC, Disease, United, Patient, Coagulation, Circulatory system, Cancer, Growth, Dentistry

Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.

Key Points: 
  • Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.
  • However, the risks associated with electrosurgical procedures and the shortage of surgeons restrain the growth of this market.
  • The report also includes an extensive assessment of the key growth strategies adopted by leading market players over the past three years.
  • The global electrosurgery market has witnessed several product launches, product approvals, acquisitions, and expansions in the last couple of years.

Mom, Doctor Who Needed Blood Urges Donors to Save Lives with Vitalant

Retrieved on: 
星期三, 五月 8, 2024
Cancer, Donation, Embolism, Blood transfusion, Blood, Amniotic fluid, Life, Family, Patient, Obstetrics, Mother, Gynaecology, Medical device

SCOTTSDALE, Ariz., May 8, 2024 /PRNewswire/ -- About one in 83 hospital deliveries requires a lifesaving blood transfusion among the nearly 3.6 million births in the U.S. each year. As Mother's Day approaches, nonprofit Vitalant urges blood donors to give in honor and celebration of mothers and all those whose emergency or planned medical procedures rely on donated blood.

Key Points: 
  • As Mother's Day approaches, nonprofit Vitalant urges blood donors to give in honor and celebration of mothers and all those whose emergency or planned medical procedures rely on donated blood.
  • Blood donation is a cause that's always been meaningful to Marci Peralto, having become a blood donor as a teenager and a doctor of obstetrics and gynecology as an adult.
  • She'll celebrate her 10th Mother's Day since donated blood helped save her life in the minutes following her son Noah's birth.
  • Vitalant needs to continually collect blood and platelet donations from generous, volunteer donors, because a patient needs blood every two seconds and donated blood can't be stored indefinitely.

NCCN Policy Summit Encourages Conversation and Action on Sexual Health and Fertility Issues Faced by People with Cancer

Retrieved on: 
星期一, 五月 6, 2024
Education, Adolescence, Fertility, City, Research, National LGBT Cancer Network, Doctor of Philosophy, Gynecologic Oncology (journal), Life, ASCO, Cancer, Concurrent estate, Cervical cancer, Virtual, Cancer prevention, NCCN, Fertility preservation, Infertility, National Comprehensive Cancer Network, Oncology, Survivor, JD, Reproductive Sciences, Quality of life, Patient, OBGYN, Gynaecology, Family, MPH, Division, Fox Chase Cancer Center, Human, Assistant professor, Policy, Associate professor, Obstetrics, UCSF, MBA, Birth control

WASHINGTON, May 6, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—hosted an oncology policy summit, today, focused on how sexual and reproductive health can impact people with cancer before, during, and after treatment. Speakers covered a wide range of topics, within the context of gender and sex, intimacy, fertility and reproductive health, treatment side-effects, and the impact of a changing policy landscape in the wake of new laws and judicial decisions.

Key Points: 
  • WASHINGTON, May 6, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—hosted an oncology policy summit, today, focused on how sexual and reproductive health can impact people with cancer before, during, and after treatment.
  • These evidence-based expert consensus recommendations feature best practices for addressing sexual health, fertility, hormone-related symptoms, and many other late and long-term effects from cancer.
  • "It is so important that education about sexual and reproductive health be included into the training of cancer clinicians if these critical health issues are to be addressed in patients' comprehensive cancer care."
  • Two afternoon keynote speakers shared first-hand looks at the issue of reproductive health and fertility preservation for people undergoing cancer care.

Women’s health in Calgary gets multi-year boost thanks to $10M investment through Calgary Health Foundation

Retrieved on: 
星期五, 五月 3, 2024
Education, Management, University, AHS, Investment, Medicine, Woman, Policy, Research, Obstetrics, Gynaecology, Obstetrics and gynaecology, Attention, Osteoporosis, Disease, Mental health, AWHF, Urogynecology, Diagnosis, Breast cancer, Government

Calgary, Alberta, Canada, May 03, 2024 (GLOBE NEWSWIRE) -- Calgary Health Foundation announces a $10M investment over two years from the Government of Alberta in support of women’s health initiatives.

Key Points: 
  • Calgary, Alberta, Canada, May 03, 2024 (GLOBE NEWSWIRE) -- Calgary Health Foundation announces a $10M investment over two years from the Government of Alberta in support of women’s health initiatives.
  • Calgary Health Foundation is committed to further funding female-related clinical care, research, and education.
  • Reproductive health, pelvic floor health, mental health, autoimmune disorders, chronic conditions, and diseases like cardiovascular disease and osteoporosis disproportionally impact women.
  • The $10M investment to Calgary Health Foundation, combined with donor support, will launch women’s health outcomes in a positive direction.

Boston IVF Welcomes Dr. Josette Dawkins to its Springfield Fertility Center, Further Enhancing Access to Expert Reproductive Care in Western Massachusetts

Retrieved on: 
星期一, 四月 29, 2024
University, Hysterosalpingography, PCOS, Suite, REI, MD, Fertility, Rochester Regional Health, Baystate, HSG, Obstetrics, IVF, Gynaecology, University of Massachusetts, Family, Medicine, Assistant, IUI, Medical director, Semen analysis, Nursing

SPRINGFIELD, Mass., April 29, 2024 /PRNewswire-PRWeb/ -- Boston IVF, one of the world's most experienced fertility treatment providers, which has assisted in over 150,000 babies born since 1986, is pleased to announce the addition of reproductive endocrinologist, Dr. Josette Dawkins, MD to its Springfield, MA fertility center and team.

Key Points: 
  • The addition of Dr. Josette Dawkins to Boston IVF and its fertility clinic in Springfield enriches the accessibility of timely reproductive care for individuals seeking to start a family.
  • She joins Boston IVF from Baystate Reproductive Medicine in Springfield, MA – where she served as its Medical Director.
  • "We are thrilled to extend a warm welcome to Dr. Josette Dawkins as she joins our esteemed Boston IVF team in Springfield, Massachusetts," expressed David Stern, CEO of Boston IVF.
  • "I am honored to become part of the respected team at Boston IVF," said Dr. Josette Dawkins.

NORTHSHORE HEALTH CENTERS ANNOUNCES MERGER WITH OBSTETRICAL & GYNECOLOGICAL ASSOCIATES

Retrieved on: 
星期二, 四月 23, 2024
OGA, North, Woman, Chiropractic, Private practice, Insurance, Obstetrics, Patient, Mental health, Physician, Practitioner, Pharmacy, Nursing

MUNSTER, Ind., April 23, 2024 (GLOBE NEWSWIRE) -- NorthShore Health Centers and Obstetrical & Gynecological Associates have merged to create a more comprehensive healthcare experience for patients throughout the region, it was announced today.

Key Points: 
  • MUNSTER, Ind., April 23, 2024 (GLOBE NEWSWIRE) -- NorthShore Health Centers and Obstetrical & Gynecological Associates have merged to create a more comprehensive healthcare experience for patients throughout the region, it was announced today.
  • Northshore currently has more than 20 locations between full-service clinics and primary care clinics in local school districts that provide medical, dental, vision, chiropractic, mental health and medication assistance through on-site pharmacies.
  • The new locations will enable the company to provide accessible care to a wider patient base.
  • OGA Valparaiso office, which offers advanced obstetrical and gynecological care throughout Northwest Indiana, is staffed with female doctors, nurse practitioners and midwives and has been operating for more than 50 years.

Compass Diversified-Backed The Honey Pot Co. Strengthens Its Board With The Appointment of Three New Directors

Retrieved on: 
星期四, 四月 18, 2024
Honey, Astral, Woman, PepsiCo, Jue, Health, Marketing, Johnson & Johnson, Cargill, Growth, Female, Obstetrics, Gynaecology, Knowledge, Entrepreneurship, Carrier oil, Human, Medical device, Booz Allen Hamilton, Honeypot, Beauty, Medical director, Kraft Foods, TED, Management

Prior to Johnson & Johnson, Ms. Smith-Gomez held general management and marketing roles at Mars, Kraft Foods, and PepsiCo.

Key Points: 
  • Prior to Johnson & Johnson, Ms. Smith-Gomez held general management and marketing roles at Mars, Kraft Foods, and PepsiCo.
  • She currently sits on the boards of The New York Academy of Medicine, Envoy Medical Corporation, and Black Public Media.
  • Ms. Wong currently sits on the board of FireFly Automatix and on the advisory board of Versicolor Technologies.
  • “Welcoming Janis, Maria, and JuE to our board is a testament to our commitment to empowering humans and promoting holistic wellness.

Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage

Retrieved on: 
星期三, 五月 1, 2024
Health, Consumer, Women, Genetics, Baby, Maternity, Clinical Trials, Biotechnology, Fetus, Nucleic acid thermodynamics, Gamma globulin, Episcopal conference, American College, NTRA, Laboratory, RHD (gene), Anemia, Risk, Pregnancy, Blood, Northwell Health, Quality, Genetic testing, Obstetrics, DNA, SNP, ACOG, ASHG, NIPT, Patient, Human genetics, Society, Physician, Antibody, Panorama, Dietary supplement

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced the launch of a new cfDNA-based fetal RhD test.

Key Points: 
  • Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced the launch of a new cfDNA-based fetal RhD test.
  • This comes at a critical time for the healthcare industry, helping physicians navigate patient care given nationwide shortages of Rho(D) immune globulin therapy (RhIg).
  • Natera’s test can be performed as early as nine weeks gestation and determines fetal RhD status from the blood of a pregnant patient, including complex pseudogene and RhD-CE-D hybrid variants.
  • The vast majority of other NIPT laboratories do not offer fetal RhD assessment, which makes it a key differentiator in addition to Natera’s core SNP-based technology.

UbiSim Virtual Reality EdTech Platform Enhanced with New Therapeutic Communication Scenarios for Nurse Learners

Retrieved on: 
星期二, 四月 30, 2024
Hardware, Technology, Education, Training, Managed Care, Professional Services, Neurology, LGBTQ+, Science, DEI (Diversity, Equity and Inclusion), Software, Consumer, Nursing, Health, Research, Alzheimer's disease, Respect, Learning, MSN, Virtual reality, Hospital, Agitation, Nose, Stomach, LGBT, Kaiser Family Foundation, Male, Communication, Conference, KFF, Catalog, Life, Obstetrics, STEM, Black, Environment, VR, Family, Mental health, Patient, Realism, RN, Next Generation, Pediatrics, Multimedia, Student, Knowledge

Learners practice administering medications and providing therapeutic communication to assist Morgan in this scenario that aligns with Nursing Fundamentals.

Key Points: 
  • Learners practice administering medications and providing therapeutic communication to assist Morgan in this scenario that aligns with Nursing Fundamentals.
  • Learners practice administering medications and providing therapeutic communication to assist Morgan in this scenario that aligns with Nursing Fundamentals.
  • In addition to the two new scenarios, updates to the UbiSim platform include a major new functionality related to the UbiSim intuitive editor.
  • Nurse educators can now customize their UbiSim nursing scenarios by adding an NG tube, while nurse learners are able to install an NG tube on any patient within the simulations.